Scleroderma & Systemic Sclerosis
"Tight, hard, or shiny skin that feels like it's shrinking or pulling"
What is Chronic Migraine?
Scleroderma (also called Systemic Sclerosis) is a chronic autoimmune disease characterized by excessive collagen production causing hardening and tightening of the skin and connective tissues. In systemic forms, it affects internal organs including the lungs, heart, kidneys, and digestive tract. The condition affects approximately 75,000-100,000 people in the United States, with women being 4 times more likely to develop it than men. The disease typically manifests between ages 30-50 and progresses slowly, with symptoms ranging from mild skin thickening to life-threatening organ involvement.
Healthy Function
What your body should do
In a healthy individual, the immune system maintains tolerance and does not attack the body's own tissues. Fibroblasts (cells that produce collagen) function normally, producing just enough collagen to maintain skin elasticity, wound healing, and tissue repair. Blood vessels maintain normal tone and respond appropriately to temperature changes, keeping fingers warm and well-perfused. The digestive tract has normal motility, allowing smooth passage of food. The lungs maintain elasticity for normal breathing. The heart pumps efficiently without restriction. The kidneys regulate blood pressure and fluid balance without damage. The extracellular matrix maintains proper balance between collagen production and breakdown.
When Things Go Wrong
Signs of chronification
- Pain threshold lowers over time
- More frequent attacks
- Brain stays in alert mode
- Medication stops working
How This Develops
Understanding the biological mechanisms helps us target the root cause
Point 1
Understanding the mechanism helps us target the root cause rather than just treating symptoms.
Conditions That Occur Together
These conditions often coexist with chronic migraine due to shared mechanisms
Raynaud's Phenomenon
Present in 90-95% of scleroderma patients; vascular dysfunction causes exaggerated vasoconstriction in response to cold or stress; can precede other symptoms by years
Pulmonary Hypertension
Vascular changes in lung arteries cause increased pressure; more common in limited cutaneous form with anti-centromere antibodies; leads to right heart failure
Interstitial Lung Disease
Fibrosis of lung tissue reduces oxygen exchange; associated with anti-Scl-70 antibodies; leading cause of mortality in diffuse cutaneous form
Gastroesophageal Reflux Disease (GERD)
Smooth muscle dysfunction in lower esophageal sphincter causes severe reflux; esophageal dysmotility impairs clearance; can lead to Barrett's esophagus
Small Intestinal Bacterial Overgrowth (SIBO)
Intestinal dysmotility allows bacterial proliferation; causes bloating, malabsorption, and nutrient deficiencies
Sjögren's Syndrome
Autoimmune attack on moisture-producing glands; common overlap with scleroderma; causes dry eyes and dry mouth
Autoimmune Thyroiditis
Shared autoimmune mechanisms; Hashimoto's thyroiditis commonly co-occurs with scleroderma
Primary Biliary Cholangitis
Autoimmune bile duct destruction; more common in limited cutaneous form with anti-centromere antibodies
Inflammatory Arthritis
Joint inflammation and pain; may overlap with rheumatoid arthritis features
Carpal Tunnel Syndrome
Wrist tissue swelling compresses median nerve; common early symptom from tissue edema
Conditions to Rule Out
These conditions can present similarly but have distinct features
Nephrogenic Systemic Fibrosis
Skin thickening and hardening
History of gadolinium contrast exposure in kidney disease; no Raynaud's phenomenon; no autoantibodies
Eosinophilic Fasciitis
Skin thickening, joint contractures
Rapid onset; prominent eosinophilia on blood tests; spares hands and face; no Raynaud's; different histology
Chronic Graft-Versus-Host Disease
Skin fibrosis, sicca symptoms
History of bone marrow or stem cell transplant; different pattern of skin involvement
Diabetic Sclerodactyly
Thickening of finger skin
History of diabetes; limited to hands; peau d'orange appearance; no systemic features
Mixed Connective Tissue Disease
Raynaud's, arthritis, esophageal dysmotility
High titer anti-U1-RNP antibodies; features of multiple autoimmune diseases; milder course
Undifferentiated Connective Tissue Disease
Raynaud's, mild symptoms
Symptoms present but don't meet criteria for specific disease; may evolve into scleroderma
Systemic Lupus Erythematosus
Fatigue, arthritis, Raynaud's
Different rash patterns; anti-dsDNA and anti-Sm antibodies; no significant skin fibrosis
Dermatomyositis
Skin changes, muscle weakness
Heliotrope rash, Gottron's papules; proximal muscle weakness; elevated muscle enzymes
What's Driving Your Migraines
Identifying the underlying causes allows us to target treatment effectively
Genetic Predisposition
Modest genetic component; 1.5-2% familial aggregationFamily history of autoimmune disease; HLA typing (HLA-DRB1*11, HLA-DQA1); non-HLA genes (IRF5, STAT4, CD247)
Environmental Triggers
May initiate disease in susceptible individualsHistory of silica exposure (miners, foundry workers); solvent exposure; epoxy resins; viral infections
Viral Infections
May trigger autoimmune response through molecular mimicryEBV serology; CMV antibodies; parvovirus B19; retroviruses
Epigenetic Changes
DNA methylation patterns altered in scleroderma fibroblastsResearch settings; family history of environmental exposures
Microchimerism
Fetal cells persisting in maternal circulation may trigger graft-versus-host-like reactionHistory of pregnancies; more common in women with prior pregnancies
Oxidative Stress
Free radical damage to endothelial cells initiates vascular injuryAdvanced lipid peroxidation markers; antioxidant status; isoprostanes
Gut Dysbiosis
Altered microbiome may influence immune regulationComprehensive stool analysis; intestinal permeability testing; SIBO breath testing
Chronic Stress and Trauma
Stress may trigger or exacerbate autoimmune processesStress history; cortisol patterns; HPA axis function
Key Laboratory Markers
These biomarkers help us understand your specific migraine mechanisms
What Happens If Left Untreated
Understanding the consequences helps you make informed decisions about your health
Progressive Skin Fibrosis
Months to yearsSevere limitation of joint movement; contractures; difficulty with daily activities; cosmetic disfigurement
Pulmonary Fibrosis
2-10 yearsIrreversible lung scarring; progressive shortness of breath; oxygen dependence; leading cause of death in diffuse form
Pulmonary Hypertension
Variable; can develop suddenlyRight heart failure; severely limited exercise capacity; high mortality without treatment
Scleroderma Renal Crisis
Can occur acutelyMalignant hypertension; acute kidney failure; requires dialysis; 50% mortality without prompt ACE inhibitor treatment
Heart Failure and Arrhythmias
ProgressiveMyocardial fibrosis causes heart failure; conduction abnormalities; sudden cardiac death risk
Digital Amputation
Progressive vascular diseaseSevere Raynaud's with digital ulcers progressing to gangrene; may require finger/toe amputation
Malnutrition and Cachexia
ProgressiveSevere GI dysmotility leads to weight loss, vitamin deficiencies, muscle wasting
Aspiration Pneumonia
Acute riskEsophageal dysmotility causes aspiration; recurrent infections; respiratory failure
Gastric Antral Vascular Ectasia (GAVE)
ProgressiveWatermelon stomach causes chronic bleeding; iron deficiency anemia; may require transfusions
Increased Mortality
Over disease courseStandardized mortality ratio 3-7 times higher than general population; 10-year survival 50-80% depending on subtype
Time Matters
Don't wait for symptoms to worsen. Early intervention leads to better outcomes.
How is Chronic Migraine Diagnosed?
Comprehensive evaluation to identify triggers, contributing factors, and appropriate treatment
ANA with Reflex Panel
Purpose:
Screen for autoimmune disease
Positive in 90-95% of scleroderma; pattern suggests specific autoantibodies
Scleroderma-Specific Antibodies
Purpose:
Confirm diagnosis and subtype
Anti-Scl-70 (diffuse disease, lung fibrosis), Anti-centromere (limited disease, CREST), Anti-RNA Pol III (diffuse, renal crisis risk)
Modified Rodnan Skin Score (mRSS)
Purpose:
Assess skin fibrosis severity
Pinching skin at 17 body sites; score 0-51; tracks disease progression
High-Resolution CT of Chest
Purpose:
Detect interstitial lung disease
Ground glass opacities, reticular changes, honeycombing; extent of fibrosis
Echocardiogram with Estimated RVSP
Purpose:
Screen for pulmonary hypertension
Right ventricular systolic pressure; right heart function; pericardial effusion
Right Heart Catheterization
Purpose:
Confirm pulmonary hypertension
Gold standard; measures pulmonary artery pressures directly; assesses treatment response
Pulmonary Function Tests
Purpose:
Assess lung function
Reduced DLCO (gas exchange); restrictive pattern; monitors progression
6-Minute Walk Test
Purpose:
Functional assessment
Exercise capacity; oxygen desaturation with activity
Barium Swallow or Esophageal Manometry
Purpose:
Assess esophageal function
Dysmotility; reduced lower esophageal sphincter pressure; reflux
Gastric Emptying Study
Purpose:
Assess stomach motility
Delayed gastric emptying; gastroparesis
Renal Function Monitoring
Purpose:
Early detection of renal crisis
Rising creatinine; proteinuria; new hypertension
Nailfold Capillaroscopy
Purpose:
Assess microvascular changes
Giant capillaries, hemorrhages, avascular areas; diagnostic and prognostic value
Supporting Your Treatment
Evidence-based lifestyle modifications to enhance treatment effectiveness
Anti-inflammatory diet: Emphasize omega-3 rich foods (wild salmon, sardines, walnuts, flaxseeds) to reduce inflammation
Antioxidant-rich foods: Colorful vegetables and fruits, especially berries, leafy greens, bell peppers - combat oxidative stress
Turmeric and ginger: Natural anti-inflammatory spices; use liberally in cooking
Vitamin C-rich foods: Citrus, kiwi, bell peppers - support collagen health and immune function
Avoid processed foods: Eliminate refined sugars, processed meats, artificial additives that promote inflammation
Limit sodium: Important for blood pressure control, especially with renal involvement
Small, frequent meals: Better tolerated with esophageal dysmotility and gastroparesis
Soft, moist foods: Easier to swallow with esophageal involvement
Stay upright after eating: Remain upright 2-3 hours after meals to reduce reflux
Adequate hydration: 8-10 glasses water daily; supports circulation and tissue health
Avoid alcohol: Can worsen reflux and interact with medications
Limit caffeine: May worsen Raynaud's phenomenon in some patients
What Success Looks Like
Skin score stabilization or improvement (Modified Rodnan Skin Score)
Stable or improved pulmonary function tests (DLCO, FVC)
No evidence of pulmonary hypertension on echocardiogram
Stable renal function (creatinine, blood pressure)
Reduced frequency and severity of Raynaud's attacks
Healing of digital ulcers
Improved 6-minute walk distance
Reduced reflux symptoms
Maintained or improved joint range of motion
Stable or improved quality of life scores
No hospitalizations for disease flares
Ability to perform activities of daily living
Maintenance of nutritional status and healthy weight
Stable cardiac function
Frequently Asked Questions
Ready to Find Relief from Chronic Migraines?
Our integrative approach has helped hundreds of patients find lasting relief from chronic migraines. Schedule your comprehensive assessment today.